SCHEMBL12467403

SCHEMBL12467403

CCC(=O)C(NC(=O)Cc1ccc2c(c1)OCO2)C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
CYP3A4 P08684 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
P2RX7 Q99572 1/20 0.48
HPGD P15428 4/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HSD17B10 Q99714 2/20 0.46
MAPK8 P45983 1/20 0.45
MAPK1 P28482 1/20 0.45
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CYP2D6 P10635 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12413584 0.88 ALDH1A1 (0.51) ALDH1A1CYP3A4CYP1A2CYP2C19P2RX7
SCHEMBL12401288 0.87 P2RX7 (0.51) ALDH1A1CYP3A4CYP1A2CYP2C19P2RX7
SCHEMBL14943390 0.79 MAPT (0.37) ALDH1A1CYP3A4CYP1A2CYP2C19P2RX7
SCHEMBL6136261 0.78 ALDH1A1 (0.56) ALDH1A1CYP3A4CYP1A2CYP2C19HPGD
SCHEMBL12330572 0.78 ALDH1A1 (0.53) ALDH1A1CYP3A4CYP1A2CYP2C19HPGD
SCHEMBL12482254 0.75 POLB (0.54) ALDH1A1CYP3A4CYP1A2CYP2C19HPGD
SCHEMBL13359258 0.75 HPGD (0.64) ALDH1A1CYP3A4CYP1A2CYP2C19HPGD
SCHEMBL8574155 0.75 ALDH1A1 (0.62) ALDH1A1CYP3A4CYP1A2CYP2C19HPGD
SCHEMBL1272814 0.75 ALDH1A1 (0.62) ALDH1A1CYP3A4CYP1A2CYP2C19HPGD
SCHEMBL7495851 0.73 CYP3A4 (0.64) ALDH1A1CYP3A4CYP1A2CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985762-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-26 US disclosed
US-20070179167-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179167-A1 Inhibitors of serine proteases PRSS1, PRSS3, PRSS2 ALDH1A1 1374/4885CYP3A4 219/4885CYP1A2 1349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.